Consists of a primosome complex and a PolIII holoenzyme comp

Consists of a primosome complex and a PolIII holoenzyme complex where each PolIII holoenzyme complex can be further divided into three different complexes, the sliding clamp and the clamp loader. The core polymerase needs the sliding clamp for processivity, which in turn is loaded onto the DNA by the clamp loader. A fairly unexploited class of compounds that has attracted attention as putative antimicrobials is peptides. The extensively studied natural antimicrobial peptides are produced by multicellular organisms and the majority act by insertion and alteration/ damage of cytoplasmic membranes via formation of ion channels or transmembrane pores, but other have been associated with MCE Company CY5 intracellular targets such as DNA and RNA synthesis and inhibition of enzymatic activities. This indicates that certain peptides can traverse the bacterial membrane to find their intracellular targets. This suggests that synthetic peptides may be tailored for use as inhibitors of intracellular targets, as proven for synthetic linear peptides targeting holiday junction resolution. A major limitation for the clinical use of antimicrobial peptides is poor proteolytic stability. This may in part be overcome by cyclization, which also confers conformation which may also influence the biological activity of the peptides. Here we report the identification of small cyclic peptides with the ability to prevent dimerization of the b-clamp and hence DNA replication in S. aureus. Peptide circularization in vivo was achieved by manipulation of protein splicing which utilizes the DnaE split intein of Synechocystic sp. PCC6803. This method coupled to reverse bacterial two-hybrid system allowed us to select peptides that were able to decrease protein-protein interactions of selected pairs of replication proteins. Peptides targeting DnaN-DnaN interaction were further characterized with respect to target specificity and activity. A similar approach has earlier been used to identify cyclic peptides that INNO-406 structure inhibit the E. coli ribonucleotide reductase by hampering association between NrdA and NrdB subunits. We have used a reverse two hybrid system to identify small cyclic peptides of 8 amino acids that reduce dimerization of the S. aureus b-sliding clamp when expressed in E. coli. Some peptides were able